Discover the hottest science in the prevention and treatment of heart rhythm disorders at EHRA 2024, a scientific congress of the European Society of Cardiology . The annual congress of the European Heart Rhythm Association , a branch of the ESC, will be held 7 to 9 April at the CityCube Berlin, Germany, and online. Explore the scientific programme.
More than 120 scientific sessions will showcase the most topical issues in the field. Sustainability is the focus of two sessions exploring whether remote cardiac monitoring can reduce greenhouse gas emissions, when to resterilize and reimplant pacemakers, and whether it is ethical not to reuse catheters and cardiac devices.
Artificial update: multiple sessions examining the pros and cons of AI for the prediction of atrial fibrillation, stroke and sudden cardiac death, and for personalized diagnosis and therapy. Not to miss: difficult decisions in patients with cancer and arrhythmias. "Contemporary issues include the feasibility of anti-cancer radiotherapy in patients with an implantable cardiac device," said Professor Merino. "Patients with cancer have a heightened risk of bleeding and there has been concern over the use of anticoagulation to treat arrhythmias but research has shown that the benefits outweigh the risks.